论文部分内容阅读
甲氧乙心安(Metoprolol)是新型β受体阻滞剂。我科用何济公药厂生产的甲氧乙心安治疗原发性高血压82例,收到较好疗效。现将临床观察结果报导如下。一、一般资料 1.病例选择:本文82例,均作详细体检及辅助检查,已排除症状性高血压。按1979年郑州会议规定的高血压诊断标准、分期、和疗效评定标准确诊为原发性高血压病。其中Ⅰ期21例、Ⅱ期51例、Ⅲ期10例。 2.疗效评定标准: 显效:①舒张压虽未降至正常,但已下降20mmHg以上,②舒张压下降10mmHg及以上,并达到正常范围。有效:①舒张压下降不及10mmHg,但已达到正
Metoprolol is a new beta-blocker. My Section Heji Gong pharmaceutical production of metoprolol treatment of essential hypertension in 82 cases, received a good effect. The clinical observations are reported below. First, the general information 1. Case Selection: This article 82 cases were examined in detail and auxiliary examination, have ruled out the symptoms of hypertension. According to the diagnostic criteria of Zhengzhou meeting in 1979, staging, and efficacy evaluation criteria for the diagnosis of essential hypertension. Among them, 21 cases were stage Ⅰ, 51 cases were stage Ⅱ and 10 cases were stage Ⅲ. 2. Efficacy evaluation criteria: markedly effective: ① diastolic blood pressure did not fall to normal, but it has dropped 20mmHg or more, ② diastolic blood pressure decreased 10mmHg and above, and reached the normal range. Effective: ① diastolic blood pressure less than 10mmHg, but has reached positive